FARINA, ANTONIETTA
 Distribuzione geografica
Continente #
NA - Nord America 2.406
EU - Europa 1.470
AS - Asia 871
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 7
SA - Sud America 5
AF - Africa 2
Totale 4.768
Nazione #
US - Stati Uniti d'America 2.402
IE - Irlanda 511
CN - Cina 383
SG - Singapore 239
TR - Turchia 207
IT - Italia 198
SE - Svezia 191
DE - Germania 166
UA - Ucraina 126
GB - Regno Unito 114
FI - Finlandia 70
FR - Francia 39
CZ - Repubblica Ceca 29
VN - Vietnam 20
BE - Belgio 17
IN - India 8
KR - Corea 8
EU - Europa 7
BR - Brasile 5
AU - Australia 4
CA - Canada 4
NZ - Nuova Zelanda 3
RU - Federazione Russa 3
HK - Hong Kong 2
AE - Emirati Arabi Uniti 1
CH - Svizzera 1
EG - Egitto 1
ID - Indonesia 1
IL - Israele 1
NL - Olanda 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 4.768
Città #
Chandler 521
Dublin 511
Jacksonville 511
Singapore 191
Boardman 180
Izmir 100
Nanjing 96
Wilmington 83
San Mateo 79
Santa Clara 78
New York 76
Lawrence 67
Princeton 67
Ashburn 53
Beijing 53
Ann Arbor 52
Dearborn 42
L'aquila 41
Nanchang 37
Milan 35
Shenyang 31
Brno 28
Verona 27
Woodbridge 23
Hebei 22
Tianjin 21
Dong Ket 20
Falls Church 20
Munich 19
Seattle 18
Brussels 17
Des Moines 17
Jinan 15
Helsinki 14
Mountain View 14
Bremen 13
Jiaxing 12
Los Angeles 12
Rome 11
Guangzhou 10
Kunming 10
L’Aquila 10
Norwalk 10
Auburn Hills 9
Changsha 9
Philadelphia 8
Shanghai 8
Hefei 7
Ningbo 7
Dallas 6
Hangzhou 6
Impruneta 6
Kitzingen 6
Taizhou 6
Washington 6
West Jordan 6
Lanzhou 5
San Francisco 5
Changchun 4
Strasbourg 4
Zhengzhou 4
Bologna 3
Catania 3
Pollenza 3
Toronto 3
Altidona 2
Aquila 2
Auckland 2
Berlin 2
Borås 2
Cambridge 2
Cava de' Tirreni 2
Cedar Knolls 2
Central 2
Chieti 2
Fairfield 2
Ferentino 2
Haikou 2
Lanciano 2
Mumbai 2
Redwood City 2
Sora 2
Taiyuan 2
Trieste 2
Amsterdam 1
Aracaju 1
Aversa 1
Bangkok 1
Belgrade 1
Bratislava 1
Brisbane 1
Bucharest 1
Campobasso 1
Canberra 1
Charlotte 1
Chengdu 1
Chongqing 1
Cleveland 1
Curitiba 1
Dubai 1
Totale 3.445
Nome #
Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression. 105
TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptation 105
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TRKIII in SH-SY5Y cells, unveiling a potential therapeutic “Achilles heel” for the TrkAIII oncoprotein in neuroblastoma 104
NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis 101
The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells 99
Constitutive autotaxin transcription by Nmyc-amplified and non-amplified neuroblastoma cells is regulated by a novel AP-1 and SP-mediated mechanism and abrogated by curcumin 92
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma 90
Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es) 89
Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in Neuroblastoma 84
Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappa B elements 84
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells 82
All-trans-retinoic acid induces nuclear factor kappa B activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma cells 81
Thioredoxin alters the matrix metalloproteinase/tissue inhibitors of metalloproteinase balance and stimulates human SK-N-SH neuroblastoma cell invasion 81
Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity 80
Cis Golgi network-associated TrkAIII targets the interphase centrosome and promotes genetic instability 78
Structure-activity relationships of calmodulin antagonism by triphenylethylene antiestrogens. 75
TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype. 75
The enemy from within: Miss-localization of a compromised receptor as a mechanism for TrkAIII oncogenic activity 75
fos/jun and octamer-binding protein interact with a common site in a negative element of the human c-myc gene. 75
Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent 73
NGF FLIPs TrkA onto the death TRAIL in neuroblastoma cells 73
Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells. 72
Neurotrophin and Neurotrophin Receptor Involvement in Human Neuroblastoma 72
Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain. 72
Two gamma-interferon-activation sites (GAS) on the promoter of the human intercellular adhesion molecule 1 (ICAM-1) gene are required for induction of transcription by IFN-gamma 71
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype. 71
CELL-SPECIFIC BIFUNCTIONAL ROLE OF JUN ONCOGENE FAMILY MEMBERS ON GLUCOCORTICOID RECEPTOR-DEPENDENT TRANSCRIPTION 71
FOLLICLE-STIMULATING HORMONE INCREASES THE EXPRESSION OF TISSUE INHIBITORS OF METALLOPROTEINASES TIMP-1 AND TIMP-2 AND INDUCES TIMP-1 AP-1 SITE BINDING COMPLEX(ES) IN PREPUBERTAL RAT SERTOLI CELLS 70
AN EARLY RESPONSE OF AN AP1-JUND COMPLEX DURING T-CELL ACTIVATION 70
Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif. 69
TRASFORMING GROWTH FACTOR-BETA 1 ENHANCES THE INVASIVITY OF HUMAN MDBA-MB-231 BREAST CANCER CELLS BY UP REGULATING UROKINASE ACTIVITY 68
Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells. 68
TrkAIII expression in the thymus 68
Alternative TrkA splicing and neuroblastoma 67
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced Death of SH-SY5Y Neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, whitin the context of a tumour stem cell-like phenotype 67
The Alternative TrkAIII splice variant by neuroblastomas and glioblastomas targets the centrosome and promotes genetic instability 67
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII 67
Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. 66
Alternative TrkAIII splicing and Cancer 66
T-cell restricted and unrestricted expression of transfected human interleukin-2 gene: phorbol ester- and calcium-inducible versus constitutive expression. 64
A pilot study of alternative TrkAIII splicing in Merkel cell carcinoma: a potential oncogenic mechanism and novel therapeutic target 64
AUTOIMMUNE ANTIGEN KU IS ENRICHED ON OLIGONUCLEOTIDE COLUMNS DISTINCT FROM THOSE CONTAINING THE OCTAMER BINDING PROTEINDNA CONSENSUS SEQUENCE 63
TRANSCRIPTIONAL MODULATION OF THE HUMAN INTERCELLULAR ADHESION MOLECULE GENE I (ICAM-1) BY RETINOIC ACID IN MELANOMA CELLS 62
TRKAIII COMMUNICATES ER-STRESS TO THE MITO-CHONDRIA IN NEUROBLASTOMA CELLS, RESULTING INGLYCOLYTIC METABOLIC ADAPTATION 62
TrkAIII: A Novel Hypoxia-regulated Alternative TrkA Splice Variant of Potential Physiological and Pathological Importance 61
Alternative TrkA splicing and Cancer 60
Transcriptional regulation of the interleukin 2 gene by glucocorticoid hormones. Role of steroid receptor and antigen-responsive 5'-flanking sequences. 60
Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastoma 58
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A 57
Thioredoxin inhibits microvascular endothelial capillary tubule formation 56
GLUCORTICOID RECEPTOR-MEDIATED SUPPRESSION OF THE INTERLEUKIN 2 GENE EXPRESSION THROUGH IMPAIRMENT OF THE COOPERATIVITY BETWEEN NUCLEAR FACTOR OF ACTIVATED T CELLS AND AP-1 ENHANCER ELEMENTS 55
POSITIVE AND NEGATIVE REGULATION OF THE COMPOSITE OCTAMER MOTIF OF THE INTERLEUKIN 2 ENHANCER BY AP-1, OCT-2, AND RETINOIC ACID RECEPTOR 54
Reconstitution of TIMP-2 expression in SH-SY5Y neuroblastoma cells by 5-azacytidine is mediated transcriptionally by NF-Y through an inverted CCAAT site 54
Tissue inhibitor of metalloproteinase-2 protection of matrix metalloproteinase-2 from degradation by plasmin is reversed by divalent cation chelator EDTA and the bisphosphonate alendronate 52
Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: A pilot study 52
A Prospective Study of Intraarterial Infusion Chemotherapy in Advanced WT BRAF Melanoma Patients 52
Multiple components are required for sequence recognition of the AP1 site in the gibbon ape leukemia virus enhancer. 51
Subcellular and extracellular localization of specific binding sites for triphenylethylene antiestrogens in human breast cancer. 51
Advanced Merkel cell carcinoma of the lower extremity treated with surgery and isolated pelvic and limb perfusion using Melphalan: A case of unexpected long-term survival 51
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer 51
Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases 50
RETINOIC ACID-ENHANCED INVASION THROUGH RECONSTITUTED BASEMENT MEMBRANE BY HUMAN SK-N-SH NEUROBLASTOMA CELLS INVOLVES MEMBRANE-ASSACIATED TISSUE-TYPE PLASMINOGEN ACTIVATOR 50
The alternative TRKAIII splice variant targets the centrosome and promotes genetic instability 49
THE KU COMPLEX IS MODULATED IN RESPONSE TO VIRAL INFECTION AND OTHER CELLULAR CHANGES 46
A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer 45
PROSTAGLANDIN E2 INHIBITS THE INTERLEUKIN-2 PROMOTER ACTIVITY THROUGH DOWN-REGULATION OF THE OCT-DEPENDENT TRANSCRIPTION OF THE OCTAMER MOTIF 44
Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting 44
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma 43
null 39
Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells 39
null 35
NGF sensitizes TrKA expressing SH-SY5Y nuroblastoma cells to TRAIL-induced apoptosisi 35
NGF Sensitizes TrkA SH-SY5Y Neuroblastoma Cells to TRAIL-Induced Apoptosis 34
Nutraceutical Preventative and Therapeutic Potential in Neuroblastoma: From Pregnancy to Early Childhood 26
Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells 22
The TrkAIII splice variant oncoprotein enhances PD-L1 expression in human SH-SY5Y neuroblastoma cells 15
A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET Progression 15
Studies on potentially druggable pathways that regulate stress-induced TrkAIII mitochondrial internalization, cleavage and activation in human neuroblastoma cells 12
Hypoxia-induced alternative TrkA splicing and reoxygenation-dependent TrkAIII activation: A cycling hypoxia-regulated resistance mechanism in neuroblastoma. 11
Totale 4.887
Categoria #
all - tutte 21.873
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.873


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020432 0 0 0 0 10 84 142 19 79 23 9 66
2020/2021581 19 66 0 69 77 21 73 9 68 24 114 41
2021/2022451 33 36 73 27 26 13 12 26 23 11 35 136
2022/20231.460 94 101 35 152 133 151 3 73 649 6 32 31
2023/2024388 49 18 38 41 29 107 1 5 5 12 7 76
2024/2025473 39 27 137 90 180 0 0 0 0 0 0 0
Totale 4.887